Recent News

• 10.02.2025 - AngioDynamics’ Fiscal 2026 First Quarter Financial Results
• 10.02.2025 - AngioDynamics’ Fiscal 2026 First Quarter Financial Results
• 10.02.2025 - AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results; Med Tech Growth of 26.1% Drives Continued Momentum
• 10.02.2025 - AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results; Med Tech Growth of 26.1% Drives Continued Momentum
• 09.24.2025 - Frank Takkinen
• 09.18.2025 - AngioDynamics to Report Fiscal 2026 First Quarter Results on October 2, 2025
• 09.18.2025 - AngioDynamics to Report Fiscal 2026 First Quarter Results on October 2, 2025
• 08.12.2025 - Canaccord Genuity 45th Annual Growth Conference
• 08.12.2025 - Canaccord Genuity 45th Annual Growth Conference
• 08.06.2025 - AngioDynamics to Present at the Canaccord Genuity 45th Annual Growth Conference

Recent Filings

• 10.02.2025 - 8-K Current report
• 10.02.2025 - EX-99.1 EX-99.1
• 10.02.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 09.25.2025 - DEF 14A Other definitive proxy statements
• 09.25.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors